NEALS COVID-19 Statement
As the COVID-19 situation continues to evolve, we know it is of particular concern for the ALS community, both for clinical care and research trials. The health and safety of people living with ALS is always our top priority and we encourage everyone to follow recommendations from their state health department, the Centers for Disease Control (CDC), and the World Health Organization (WHO). The COVID-19 pandemic may impact clinical trials and we encourage each patient to contact their physician with any questions or concerns related to COVID-19.
Representatives from the NEALS leadership team will be hosting a public webinar on Friday, March 27th from 4:00 – 5:00 PM EDT on the impact of COVID-19 on ALS clinical research. We encourage everyone to submit questions in advance by sending them to firstname.lastname@example.org. Click here to register for the webinar.